The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
No matching Grants were found.
Clinical Trials
| Title Sort descending | Intervention | Sponsor | Status |
|---|---|---|---|
| Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma | Placebo, armodafinil 150 mg, armodafinil 250 mg | Alliance for Clinical Trials in Oncology | Completed |
| Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics | Non-interventional Study | Wake Forest University Health Sciences | Recruiting |
| Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission | Behavioral Intervention, Compliance Monitoring, Laboratory Biomarker Analysis, Mercaptopurine, Questionnaire Administration, Standard Follow-Up Care | Children's Oncology Group | Active, not recruiting |
| Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors | AH-HA Tool in the EPIC EHR | Wake Forest University Health Sciences | Active, not recruiting |
| Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy | University of Rochester NCORP Research Base | Enrolling by invitation | |
| Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting | Survey Administration | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome | auranofin, placebo, questionnaire administration | Mayo Clinic | Completed |
| Axillary Reverse Mapping in Preventing Lymphedema in Patients with Breast Cancer Undergoing Axillary Lymph Node Dissection | Axillary Lymph Node Dissection, Isosulfan Blue, Mapping, Quality-of-Life Assessment, Questionnaire Administration | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma | Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis | Children's Oncology Group | Recruiting |
| Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors | Biospecimen Collection, Laboratory Biomarker Analysis, Questionnaire Administration | Children's Oncology Group | Completed |